XML 32 R15.htm IDEA: XBRL DOCUMENT v3.6.0.2
Financial Instruments
3 Months Ended
Jan. 31, 2017
Investments, All Other Investments [Abstract]  
Financial Instruments
Financial Instruments
Cash Equivalents and Available-for-Sale Investments
 
As of January 31, 2017
 
As of October 31, 2016
 
Cost
 
Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair
Value
 
Cost
 
Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair
Value
 
In millions
Cash Equivalents:
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Time deposits
$
2,280

 
$

 
$

 
$
2,280

 
$
2,092

 
$

 
$

 
$
2,092

Money market funds
2,541

 

 

 
2,541

 
2,568

 

 

 
2,568

Total cash equivalents
4,821

 

 

 
4,821

 
4,660

 

 

 
4,660

Available-for-Sale Investments:
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Marketable equity securities
1

 
6

 

 
7

 
1

 
3

 

 
4

Mutual funds
35

 
9

 

 
44

 
35

 
9

 

 
44

Other debt securities

 

 

 

 
2

 

 

 
2

Total available-for-sale investments
36

 
15

 

 
51

 
38

 
12

 

 
50

Total cash equivalents and available-for-sale investments
$
4,857

 
$
15

 
$

 
$
4,872

 
$
4,698

 
$
12

 
$

 
$
4,710


All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents. As of January 31, 2017 and October 31, 2016, the carrying amount of cash equivalents approximated fair value due to the short period of time to maturity. Time deposits were primarily issued by institutions outside the United States as of January 31, 2017 and October 31, 2016. The estimated fair value of the available-for-sale investments may not be representative of values that will be realized in the future.
Contractual maturities of investments in available-for-sale debt securities were as follows:
 
As of January 31, 2017
 
Amortized
Cost
 
Fair Value
 
In millions
Due in one year
$

 
$

Due in one to five years
$

 
$

Due in more than five years
$
35

 
$
44


Equity securities in privately held companies include cost basis and equity method investments and are included in Other non-current assets on the Consolidated Condensed Balance Sheets. These amounted to $17 million and $16 million as of January 31, 2017 and October 31, 2016, respectively.
Derivative Instruments
HP uses derivatives to offset business exposure to foreign currency and interest rate risk on expected future cash flows and on certain existing assets and liabilities. As part of its risk management strategy, HP uses derivative instruments, primarily forward contracts, interest rate swaps, total return swaps and, at times, option contracts to hedge certain foreign currency, interest rate and, to a lesser extent, equity exposures. HP may designate its derivative contracts as fair value hedges or cash flow hedges. HP classifies cash flows from its designated derivative contracts with the activities that correspond to the underlying hedged items on the Consolidated Condensed Statements of Cash Flows. For derivatives not designated as hedging instruments, HP categorizes those economic hedges as other derivatives. HP recognizes all derivative instruments at fair value in the Consolidated Condensed Balance Sheets.
As a result of its use of derivative instruments, HP is exposed to the risk that its counterparties will fail to meet their contractual obligations. Master netting agreements mitigate credit exposure to counterparties by permitting HP to net amounts due from HP to counterparty against amounts due to HP from the same counterparty under certain conditions. To further limit credit risk, HP has collateral security agreements that allow HP to hold collateral from, or require HP to post collateral to, counterparties when aggregate derivative fair values exceed contractually established thresholds which are generally based on the credit ratings of HP and its counterparties. If HP’s or the counterparty’s credit rating falls below a specified credit rating, either party has the right to request full collateralization of the derivatives’ net liability position. The fair value of derivatives with credit contingent features in a net liability position was $90 million and $2 million as of January 31, 2017 and October 31, 2016, respectively, all of which were fully collateralized within two business days of the related request.
Under HP’s derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting HP that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect HP’s financial position or cash flows as of January 31, 2017 and October 31, 2016.
Fair Value Hedges
HP enters into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in interest rates by achieving a primarily U.S. dollar London Interbank Offered Rate (“LIBOR”)-based floating interest expense.
For derivative instruments that are designated and qualify as fair value hedges, HP recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net on the Consolidated Condensed Statements of Earnings in the period of change.
Cash Flow Hedges
HP uses forward contracts and at times, option contracts designated as cash flow hedges to protect against the foreign currency exchange rate risks inherent in its forecasted net revenue and, to a lesser extent, cost of revenue, operating expenses, and intercompany loans denominated in currencies other than the U.S. Dollar. HP’s foreign currency cash flow hedges mature generally within twelve months; however, hedges related to longer term procurement arrangements extend several years and forward contracts associated with intercompany loans extend for the duration of the loan term, which typically range from two to five years.
For derivative instruments that are designated and qualify as cash flow hedges, HP initially records changes in fair value for the effective portion of the derivative instrument in accumulated other comprehensive loss as a separate component of stockholders’ deficit on the Consolidated Condensed Balance Sheets and subsequently reclassifies these amounts into earnings in the period during which the hedged transaction is recognized in earnings. HP reports the effective portion of its cash flow hedges in the same financial statement line item as changes in the fair value of the hedged item.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. HP uses total return swaps to hedge its executive deferred compensation plan liability. For derivative instruments not designated as hedging instruments, HP recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Condensed Statements of Earnings in the period of change.
Hedge Effectiveness
For interest rate swaps designated as fair value hedges, HP measures hedge effectiveness by offsetting the change in fair value of the hedged item with the change in fair value of the derivative. For foreign currency options and forward contracts designated as cash flow hedges, HP measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates. HP recognizes any ineffective portion of the hedge in the Consolidated Condensed Statements of Earnings in the same period in which ineffectiveness occurs. Amounts excluded from the assessment of effectiveness are recognized in the Consolidated Condensed Statements of Earnings in the period they arise.
The hedge ineffectiveness fair value and cash flow hedges recognized in earnings were not material for the three months ended January 31, 2017 and January 31, 2016.
Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets
The gross notional and fair value of derivative instruments in the Consolidated Condensed Balance Sheets were as follows:
 
As of January 31, 2017
 
As of October 31, 2016
 
Outstanding
Gross
Notional
 
Other Current Assets
 
Other
Non-Current
Assets
 
Other
Accrued
Liabilities
 
Other
Non-Current
Liabilities
 
Outstanding
Gross
Notional
 
Other
Current
Assets
 
Other
Non-Current
Assets
 
Other
Accrued
Liabilities
 
Other
Non-Current
Liabilities
 
In millions
Derivatives designated as hedging instruments
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Fair value hedges:
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Interest rate contracts
$
2,500

 
$

 
$
4

 
$

 
$
8

 
$
2,000

 
$

 
$
48

 
$

 
$

Cash flow hedges:
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Foreign currency contracts
12,174

 
131

 
20

 
156

 
40

 
11,852

 
203

 
63

 
52

 
12

Total derivatives designated as hedging instruments
14,674

 
131

 
24

 
156

 
48

 
13,852

 
203

 
111

 
52

 
12

Derivatives not designated as hedging instruments
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Foreign currency contracts
3,808

 
12

 
3

 
40

 
3

 
3,934

 
11

 

 
31

 

Other derivatives
152

 
1

 

 

 

 
150

 

 

 
2

 

Total derivatives not designated as hedging instruments
3,960

 
13

 
3

 
40

 
3

 
4,084

 
11

 

 
33

 

Total derivatives
$
18,634

 
$
144

 
$
27

 
$
196

 
$
51

 
$
17,936

 
$
214

 
$
111

 
$
85

 
$
12


Offsetting of Derivative Instruments
HP recognizes all derivative instruments on a gross basis in the Consolidated Condensed Balance Sheets. HP does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under its collateral security agreements. As of January 31, 2017 and October 31, 2016, information related to the potential effect of HP’s master netting agreements and collateral security agreements was as follows:
 
In the Consolidated Condensed Balance Sheets
 
 
 
 
 
 
 
 
 
 
 
Gross Amounts Not Offset
 
 
 
 
 
Gross Amount
Recognized
(i)
Gross Amount
Offset
(ii)
Net Amount
Presented
(iii) = (i)–(ii)
 
Derivatives
(iv)
 
Financial
Collateral
(v)
 
 
 
Net Amount
(vi) = (iii)–(iv)–(v)
 
In millions
As of January 31, 2017
 

 
 

 
 

 
 

 
 

 
 
 
 

Derivative assets
$
171

 
$

 
$
171

 
$
148

 
$
16

 
(1) 
 
$
7

Derivative liabilities
$
247

 
$

 
$
247

 
$
148

 
$
70

 
(2) 
 
$
29

As of October 31, 2016
 

 
 

 
 

 
 

 
 

 
 
 
 

Derivative assets
$
325

 
$

 
$
325

 
$
88

 
$
189

 
(1) 
 
$
48

Derivative liabilities
$
97

 
$

 
$
97

 
$
88

 
$
2

 
(2) 
 
$
7

_______________________________________________________________________________
(1) 
Represents the cash collateral posted by counterparties as of the respective reporting date for HP’s asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2) 
Represents the collateral posted by HP through re-use of counterparty cash collateral as of the respective reporting date for HP’s liability position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
Effect of Derivative Instruments in the Consolidated Condensed Statements of Earnings
The pre-tax effect of derivative instruments and related hedged items in a fair value hedging relationship for the three months ended January 31, 2017 and January 31, 2016 were as follows:
 
 
(Loss) Gain Recognized in Earnings on Derivative and Related Hedged Item
Derivative Instrument
 
Location
 
Three months ended January 31, 2017
 
Three months ended January 31, 2016
 
Hedged Item
 
Location
 
Three months ended January 31, 2017
 
Three months ended January 31, 2016
 
 
 
 
In millions
 
 
 
 
 
In millions
Interest rate contracts
 
Interest and other, net
 
$
(52
)
 
$
14

 
Fixed-rate debt
 
Interest and other, net
 
$
52

 
$
(14
)
The pre-tax effect of derivative instruments in cash flow hedging relationships for the three months ended January 31, 2017 was as follows
 
(Loss) Gain Recognized in
Other Comprehensive
Income (“OCI”) on Derivatives (Effective Portion)
 
Gain (Loss) Reclassified from Accumulated OCI Into
Earnings (Effective Portion)
 
Three months ended January 31, 2017
 
Three months ended January 31, 2016
 
Location
 
Three months ended January 31, 2017
 
Three months ended January 31, 2016
 
In millions
 
 
 
In millions
Cash flow hedges:
 

 
 

 
 
 
 

 
 

Foreign currency contracts
$
(169
)
 
$
105

 
Net revenue
 
$
76

 
$
78

 
 

 
 

 
Cost of revenue
 

 
(40
)
 
 

 
 

 
Interest and other, net
 
(5
)
 
(4
)
Total
$
(169
)
 
$
105

 
 
 
$
71

 
$
34

As of January 31, 2017, HP expects to reclassify an estimated accumulated other comprehensive loss (“AOCI”) of $32 million, net of taxes, to earnings within the next twelve months associated with cash flow hedges along with the earnings effects of the related forecasted transactions. The amounts ultimately reclassified into earnings could be different from the amounts previously included in AOCI based on the change of market rate, and therefore could have a different impact on earnings.
The pre-tax effect of derivative instruments not designated as hedging instruments in the Consolidated Condensed Statements of Earnings for the three months ended January 31, 2017 and January 31, 2016 was as follows:
 
Gain Recognized in Earnings on Derivatives
 
Location
 
Three months ended January 31, 2017
 
Three months ended January 31, 2016
 
 
 
In millions
Foreign currency contracts
Interest and other, net
 
$
(2
)
 
$
21

Other derivatives
Interest and other, net
 
3

 
(8
)
Total
 
 
$
1

 
$
13